Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Clinical Trial Comparing Ultraporous Beta-TCP With BMA to Combined TCP With Calcium Sulfate in Curetted Benign Bone Lesions

NCT03509480 is registered in ClinicalTrials.gov with State University of New York - Upstate Medical University as lead sponsor.

NCT NCT03509480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03509480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Clinical Trial Comparing Ultraporous Beta-TCP With BMA to Combined TCP With Calcium Sulfate in Curetted Benign Bone Lesions
Lead sponsor
State University of New York - Upstate Medical University
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2009
Completion date
February 28, 2018
Enrollment
53 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bone lesion